nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—sarcoma	0.291	0.536	CbGaD
Arsenic trioxide—JUN—sarcoma	0.252	0.464	CbGaD
Arsenic trioxide—CYP1B1—Mitoxantrone—sarcoma	0.0595	0.244	CbGbCtD
Arsenic trioxide—CYP1A1—Dacarbazine—sarcoma	0.0337	0.138	CbGbCtD
Arsenic trioxide—CYP1B1—Doxorubicin—sarcoma	0.0256	0.105	CbGbCtD
Arsenic trioxide—ABCC2—Vincristine—sarcoma	0.0215	0.0883	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—sarcoma	0.0197	0.0809	CbGbCtD
Arsenic trioxide—CYP3A4—Thiotepa—sarcoma	0.0142	0.0583	CbGbCtD
Arsenic trioxide—ABCC2—Doxorubicin—sarcoma	0.0135	0.0552	CbGbCtD
Arsenic trioxide—ABCB1—Dactinomycin—sarcoma	0.0114	0.0467	CbGbCtD
Arsenic trioxide—ABCB1—Mitoxantrone—sarcoma	0.0102	0.0418	CbGbCtD
Arsenic trioxide—ABCB1—Vincristine—sarcoma	0.00702	0.0288	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—sarcoma	0.00643	0.0264	CbGbCtD
Arsenic trioxide—CYP3A4—Mitoxantrone—sarcoma	0.00611	0.0251	CbGbCtD
Arsenic trioxide—ABCB1—Doxorubicin—sarcoma	0.00439	0.018	CbGbCtD
Arsenic trioxide—CYP3A4—Vincristine—sarcoma	0.00421	0.0172	CbGbCtD
Arsenic trioxide—CYP3A4—Etoposide—sarcoma	0.00385	0.0158	CbGbCtD
Arsenic trioxide—CCND1—larynx—sarcoma	0.00353	0.0488	CbGeAlD
Arsenic trioxide—MAPK3—periosteum—sarcoma	0.00287	0.0397	CbGeAlD
Arsenic trioxide—AKT1—periosteum—sarcoma	0.00271	0.0374	CbGeAlD
Arsenic trioxide—CYP3A4—Doxorubicin—sarcoma	0.00263	0.0108	CbGbCtD
Arsenic trioxide—JUN—periosteum—sarcoma	0.00236	0.0326	CbGeAlD
Arsenic trioxide—AKT1—leg—sarcoma	0.00216	0.0298	CbGeAlD
Arsenic trioxide—AKT1—forelimb—sarcoma	0.00214	0.0296	CbGeAlD
Arsenic trioxide—AKT1—hindlimb—sarcoma	0.00193	0.0267	CbGeAlD
Arsenic trioxide—AKT1—appendage—sarcoma	0.00165	0.0229	CbGeAlD
Arsenic trioxide—CCND1—mammary gland—sarcoma	0.00114	0.0158	CbGeAlD
Arsenic trioxide—MAPK3—endothelium—sarcoma	0.00106	0.0146	CbGeAlD
Arsenic trioxide—AKT1—endothelium—sarcoma	0.000998	0.0138	CbGeAlD
Arsenic trioxide—MAPK1—mammary gland—sarcoma	0.000964	0.0133	CbGeAlD
Arsenic trioxide—TXNRD1—mammary gland—sarcoma	0.000898	0.0124	CbGeAlD
Arsenic trioxide—JUN—endothelium—sarcoma	0.000869	0.012	CbGeAlD
Arsenic trioxide—MAPK3—mammary gland—sarcoma	0.000853	0.0118	CbGeAlD
Arsenic trioxide—CCND1—myometrium—sarcoma	0.000812	0.0112	CbGeAlD
Arsenic trioxide—AKT1—mammary gland—sarcoma	0.000805	0.0111	CbGeAlD
Arsenic trioxide—CCND1—embryo—sarcoma	0.000781	0.0108	CbGeAlD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—sarcoma	0.000741	0.332	CbGdCrCtD
Arsenic trioxide—CCND1—seminal vesicle—sarcoma	0.000734	0.0101	CbGeAlD
Arsenic trioxide—JUN—mammary gland—sarcoma	0.000701	0.00968	CbGeAlD
Arsenic trioxide—CCND1—hematopoietic system—sarcoma	0.000697	0.00964	CbGeAlD
Arsenic trioxide—CCND1—connective tissue—sarcoma	0.000671	0.00928	CbGeAlD
Arsenic trioxide—MAPK1—embryo—sarcoma	0.000658	0.0091	CbGeAlD
Arsenic trioxide—TXNRD1—myometrium—sarcoma	0.000637	0.0088	CbGeAlD
Arsenic trioxide—CCND1—smooth muscle tissue—sarcoma	0.000614	0.00849	CbGeAlD
Arsenic trioxide—CCND1—skin of body—sarcoma	0.000606	0.00838	CbGeAlD
Arsenic trioxide—MAPK3—myometrium—sarcoma	0.000606	0.00837	CbGeAlD
Arsenic trioxide—MAPK1—hematopoietic system—sarcoma	0.000588	0.00812	CbGeAlD
Arsenic trioxide—MAPK3—embryo—sarcoma	0.000582	0.00805	CbGeAlD
Arsenic trioxide—TXNRD1—seminal vesicle—sarcoma	0.000575	0.00795	CbGeAlD
Arsenic trioxide—AKT1—myometrium—sarcoma	0.000571	0.00789	CbGeAlD
Arsenic trioxide—MAPK1—connective tissue—sarcoma	0.000566	0.00782	CbGeAlD
Arsenic trioxide—AKT1—embryo—sarcoma	0.000549	0.00759	CbGeAlD
Arsenic trioxide—MAPK3—seminal vesicle—sarcoma	0.000547	0.00756	CbGeAlD
Arsenic trioxide—TXNRD1—hematopoietic system—sarcoma	0.000547	0.00756	CbGeAlD
Arsenic trioxide—CCND1—cardiac atrium—sarcoma	0.000529	0.00732	CbGeAlD
Arsenic trioxide—CCND1—uterus—sarcoma	0.000527	0.00728	CbGeAlD
Arsenic trioxide—TXNRD1—connective tissue—sarcoma	0.000527	0.00728	CbGeAlD
Arsenic trioxide—MAPK3—hematopoietic system—sarcoma	0.00052	0.00719	CbGeAlD
Arsenic trioxide—MAPK1—smooth muscle tissue—sarcoma	0.000517	0.00715	CbGeAlD
Arsenic trioxide—AKT1—seminal vesicle—sarcoma	0.000516	0.00713	CbGeAlD
Arsenic trioxide—MAPK1—skin of body—sarcoma	0.000511	0.00706	CbGeAlD
Arsenic trioxide—MAPK3—connective tissue—sarcoma	0.000501	0.00692	CbGeAlD
Arsenic trioxide—JUN—myometrium—sarcoma	0.000497	0.00687	CbGeAlD
Arsenic trioxide—IKBKB—myometrium—sarcoma	0.000495	0.00684	CbGeAlD
Arsenic trioxide—CCND1—lymphoid tissue—sarcoma	0.000491	0.00678	CbGeAlD
Arsenic trioxide—AKT1—hematopoietic system—sarcoma	0.00049	0.00678	CbGeAlD
Arsenic trioxide—TXNRD1—smooth muscle tissue—sarcoma	0.000482	0.00666	CbGeAlD
Arsenic trioxide—JUN—embryo—sarcoma	0.000478	0.00661	CbGeAlD
Arsenic trioxide—IKBKB—embryo—sarcoma	0.000476	0.00658	CbGeAlD
Arsenic trioxide—TXNRD1—skin of body—sarcoma	0.000475	0.00657	CbGeAlD
Arsenic trioxide—AKT1—connective tissue—sarcoma	0.000472	0.00653	CbGeAlD
Arsenic trioxide—CCND1—tendon—sarcoma	0.000461	0.00638	CbGeAlD
Arsenic trioxide—MAPK3—smooth muscle tissue—sarcoma	0.000458	0.00633	CbGeAlD
Arsenic trioxide—MAPK3—skin of body—sarcoma	0.000452	0.00625	CbGeAlD
Arsenic trioxide—JUN—seminal vesicle—sarcoma	0.000449	0.00621	CbGeAlD
Arsenic trioxide—MAPK1—cardiac atrium—sarcoma	0.000446	0.00617	CbGeAlD
Arsenic trioxide—MAPK1—uterus—sarcoma	0.000444	0.00613	CbGeAlD
Arsenic trioxide—AKT1—smooth muscle tissue—sarcoma	0.000432	0.00597	CbGeAlD
Arsenic trioxide—JUN—hematopoietic system—sarcoma	0.000427	0.0059	CbGeAlD
Arsenic trioxide—AKT1—skin of body—sarcoma	0.000426	0.00589	CbGeAlD
Arsenic trioxide—IKBKB—hematopoietic system—sarcoma	0.000425	0.00587	CbGeAlD
Arsenic trioxide—TXNRD1—cardiac atrium—sarcoma	0.000415	0.00574	CbGeAlD
Arsenic trioxide—MAPK1—lymphoid tissue—sarcoma	0.000414	0.00572	CbGeAlD
Arsenic trioxide—TXNRD1—uterus—sarcoma	0.000413	0.00571	CbGeAlD
Arsenic trioxide—JUN—connective tissue—sarcoma	0.000411	0.00568	CbGeAlD
Arsenic trioxide—IKBKB—connective tissue—sarcoma	0.000409	0.00565	CbGeAlD
Arsenic trioxide—MAPK3—cardiac atrium—sarcoma	0.000395	0.00546	CbGeAlD
Arsenic trioxide—MAPK3—uterus—sarcoma	0.000393	0.00543	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Epirubicin—sarcoma	0.000387	0.173	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Epirubicin—sarcoma	0.000387	0.173	CbGdCrCtD
Arsenic trioxide—TXNRD1—lymphoid tissue—sarcoma	0.000385	0.00532	CbGeAlD
Arsenic trioxide—CCND1—testis—sarcoma	0.000382	0.00528	CbGeAlD
Arsenic trioxide—MAPK1—bone marrow—sarcoma	0.000377	0.00521	CbGeAlD
Arsenic trioxide—JUN—smooth muscle tissue—sarcoma	0.000376	0.0052	CbGeAlD
Arsenic trioxide—IKBKB—smooth muscle tissue—sarcoma	0.000374	0.00517	CbGeAlD
Arsenic trioxide—CYP1B1—mammary gland—sarcoma	0.000373	0.00516	CbGeAlD
Arsenic trioxide—AKT1—cardiac atrium—sarcoma	0.000372	0.00515	CbGeAlD
Arsenic trioxide—JUN—skin of body—sarcoma	0.000371	0.00513	CbGeAlD
Arsenic trioxide—AKT1—uterus—sarcoma	0.00037	0.00512	CbGeAlD
Arsenic trioxide—IKBKB—skin of body—sarcoma	0.000369	0.0051	CbGeAlD
Arsenic trioxide—MAPK3—lymphoid tissue—sarcoma	0.000366	0.00506	CbGeAlD
Arsenic trioxide—TXNRD1—tendon—sarcoma	0.000362	0.005	CbGeAlD
Arsenic trioxide—CCND1—liver—sarcoma	0.000361	0.00499	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Doxorubicin—sarcoma	0.000358	0.16	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Doxorubicin—sarcoma	0.000358	0.16	CbGdCrCtD
Arsenic trioxide—TXNRD1—bone marrow—sarcoma	0.000351	0.00484	CbGeAlD
Arsenic trioxide—AKT1—lymphoid tissue—sarcoma	0.000345	0.00477	CbGeAlD
Arsenic trioxide—MAPK3—tendon—sarcoma	0.000344	0.00476	CbGeAlD
Arsenic trioxide—MAPK3—bone marrow—sarcoma	0.000333	0.00461	CbGeAlD
Arsenic trioxide—AKT1—tendon—sarcoma	0.000325	0.00449	CbGeAlD
Arsenic trioxide—JUN—cardiac atrium—sarcoma	0.000324	0.00448	CbGeAlD
Arsenic trioxide—JUN—uterus—sarcoma	0.000322	0.00446	CbGeAlD
Arsenic trioxide—MAPK1—testis—sarcoma	0.000322	0.00445	CbGeAlD
Arsenic trioxide—IKBKB—uterus—sarcoma	0.000321	0.00443	CbGeAlD
Arsenic trioxide—AKT1—bone marrow—sarcoma	0.000314	0.00434	CbGeAlD
Arsenic trioxide—MAPK1—liver—sarcoma	0.000304	0.00421	CbGeAlD
Arsenic trioxide—JUN—lymphoid tissue—sarcoma	0.0003	0.00415	CbGeAlD
Arsenic trioxide—TXNRD1—testis—sarcoma	0.0003	0.00414	CbGeAlD
Arsenic trioxide—IKBKB—lymphoid tissue—sarcoma	0.000299	0.00413	CbGeAlD
Arsenic trioxide—MAPK3—testis—sarcoma	0.000285	0.00394	CbGeAlD
Arsenic trioxide—TXNRD1—liver—sarcoma	0.000283	0.00392	CbGeAlD
Arsenic trioxide—JUN—tendon—sarcoma	0.000282	0.0039	CbGeAlD
Arsenic trioxide—IKBKB—tendon—sarcoma	0.000281	0.00389	CbGeAlD
Arsenic trioxide—CCND1—lymph node—sarcoma	0.000277	0.00383	CbGeAlD
Arsenic trioxide—JUN—bone marrow—sarcoma	0.000274	0.00378	CbGeAlD
Arsenic trioxide—MAPK3—liver—sarcoma	0.000269	0.00372	CbGeAlD
Arsenic trioxide—AKT1—testis—sarcoma	0.000269	0.00371	CbGeAlD
Arsenic trioxide—AKT1—liver—sarcoma	0.000254	0.00351	CbGeAlD
Arsenic trioxide—JUN—testis—sarcoma	0.000234	0.00323	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—sarcoma	0.000233	0.00323	CbGeAlD
Arsenic trioxide—IKBKB—testis—sarcoma	0.000233	0.00322	CbGeAlD
Arsenic trioxide—CYP1B1—hematopoietic system—sarcoma	0.000228	0.00314	CbGeAlD
Arsenic trioxide—JUN—liver—sarcoma	0.000221	0.00306	CbGeAlD
Arsenic trioxide—IKBKB—liver—sarcoma	0.00022	0.00304	CbGeAlD
Arsenic trioxide—CYP1B1—connective tissue—sarcoma	0.000219	0.00303	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—sarcoma	0.000217	0.003	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—sarcoma	0.000207	0.00285	CbGeAlD
Arsenic trioxide—CYP1B1—smooth muscle tissue—sarcoma	0.0002	0.00277	CbGeAlD
Arsenic trioxide—CYP1B1—skin of body—sarcoma	0.000198	0.00273	CbGeAlD
Arsenic trioxide—AKT1—lymph node—sarcoma	0.000195	0.00269	CbGeAlD
Arsenic trioxide—CYP1B1—uterus—sarcoma	0.000172	0.00238	CbGeAlD
Arsenic trioxide—JUN—lymph node—sarcoma	0.00017	0.00234	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—sarcoma	0.000169	0.00233	CbGeAlD
Arsenic trioxide—CYP1A1—hematopoietic system—sarcoma	0.000161	0.00222	CbGeAlD
Arsenic trioxide—CYP1B1—lymphoid tissue—sarcoma	0.00016	0.00221	CbGeAlD
Arsenic trioxide—ABCC2—tendon—sarcoma	0.000154	0.00213	CbGeAlD
Arsenic trioxide—CYP1B1—tendon—sarcoma	0.000151	0.00208	CbGeAlD
Arsenic trioxide—CYP1A1—skin of body—sarcoma	0.00014	0.00193	CbGeAlD
Arsenic trioxide—ABCC2—testis—sarcoma	0.000127	0.00176	CbGeAlD
Arsenic trioxide—CYP1B1—testis—sarcoma	0.000125	0.00172	CbGeAlD
Arsenic trioxide—CYP1A1—cardiac atrium—sarcoma	0.000122	0.00169	CbGeAlD
Arsenic trioxide—CYP1A1—uterus—sarcoma	0.000121	0.00168	CbGeAlD
Arsenic trioxide—ABCC2—liver—sarcoma	0.00012	0.00166	CbGeAlD
Arsenic trioxide—CYP3A4—hematopoietic system—sarcoma	0.000118	0.00163	CbGeAlD
Arsenic trioxide—CYP1B1—liver—sarcoma	0.000118	0.00163	CbGeAlD
Arsenic trioxide—ABCB1—myometrium—sarcoma	9.73e-05	0.00134	CbGeAlD
Arsenic trioxide—ABCB1—embryo—sarcoma	9.36e-05	0.00129	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—sarcoma	9.23e-05	0.00128	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—sarcoma	9.04e-05	0.00125	CbGeAlD
Arsenic trioxide—ABCB1—seminal vesicle—sarcoma	8.79e-05	0.00121	CbGeAlD
Arsenic trioxide—ABCB1—hematopoietic system—sarcoma	8.35e-05	0.00115	CbGeAlD
Arsenic trioxide—CYP1A1—liver—sarcoma	8.33e-05	0.00115	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—sarcoma	6.39e-05	0.000883	CbGeAlD
Arsenic trioxide—ABCB1—uterus—sarcoma	6.31e-05	0.000872	CbGeAlD
Arsenic trioxide—CYP3A4—liver—sarcoma	6.11e-05	0.000845	CbGeAlD
Arsenic trioxide—ABCB1—lymphoid tissue—sarcoma	5.88e-05	0.000813	CbGeAlD
Arsenic trioxide—ABCB1—bone marrow—sarcoma	5.36e-05	0.00074	CbGeAlD
Arsenic trioxide—ABCB1—testis—sarcoma	4.58e-05	0.000633	CbGeAlD
Arsenic trioxide—ABCB1—liver—sarcoma	4.33e-05	0.000598	CbGeAlD
Arsenic trioxide—ABCB1—lymph node—sarcoma	3.32e-05	0.000459	CbGeAlD
Arsenic trioxide—MAPK3—Immune System—CREB1—sarcoma	4.5e-06	3.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KIT—sarcoma	4.5e-06	3.26e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.46e-06	3.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—MYC—sarcoma	4.46e-06	3.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—KRAS—sarcoma	4.45e-06	3.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—KRAS—sarcoma	4.43e-06	3.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—sarcoma	4.37e-06	3.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—NRAS—sarcoma	4.37e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KIT—sarcoma	4.37e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—KRAS—sarcoma	4.37e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—SRC—sarcoma	4.36e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1R—sarcoma	4.35e-06	3.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—sarcoma	4.33e-06	3.13e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FOXO1—sarcoma	4.31e-06	3.12e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KIT—sarcoma	4.31e-06	3.12e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PDGFRB—sarcoma	4.3e-06	3.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CREB1—sarcoma	4.29e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CREB1—sarcoma	4.29e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—KRAS—sarcoma	4.26e-06	3.08e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PDGFRA—sarcoma	4.23e-06	3.07e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—SRC—sarcoma	4.22e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1R—sarcoma	4.22e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.22e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ENO2—sarcoma	4.21e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—sarcoma	4.21e-06	3.04e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—NRAS—sarcoma	4.2e-06	3.04e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HBA1—sarcoma	4.18e-06	3.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—sarcoma	4.16e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CREB1—sarcoma	4.16e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KIT—sarcoma	4.16e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FOXO1—sarcoma	4.14e-06	3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—sarcoma	4.14e-06	3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PDGFRB—sarcoma	4.13e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—KRAS—sarcoma	4.13e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—sarcoma	4.11e-06	2.97e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CREB1—sarcoma	4.1e-06	2.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—HRAS—sarcoma	4.1e-06	2.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—KRAS—sarcoma	4.09e-06	2.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—sarcoma	4.08e-06	2.95e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PDGFRA—sarcoma	4.07e-06	2.95e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—NRAS—sarcoma	4.06e-06	2.94e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—HRAS—sarcoma	4.02e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FOXO1—sarcoma	4.02e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1R—sarcoma	4.01e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PDGFRB—sarcoma	4.01e-06	2.9e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MDM2—sarcoma	4e-06	2.9e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—sarcoma	3.98e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—HRAS—sarcoma	3.98e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CREB1—sarcoma	3.96e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PDGFRA—sarcoma	3.95e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—KRAS—sarcoma	3.93e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—HRAS—sarcoma	3.9e-06	2.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—sarcoma	3.88e-06	2.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—sarcoma	3.85e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MDM2—sarcoma	3.84e-06	2.78e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1R—sarcoma	3.84e-06	2.78e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—sarcoma	3.82e-06	2.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FOXO1—sarcoma	3.82e-06	2.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PDGFRB—sarcoma	3.81e-06	2.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—HRAS—sarcoma	3.78e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MYC—sarcoma	3.78e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HRAS—sarcoma	3.77e-06	2.73e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—KRAS—sarcoma	3.76e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—sarcoma	3.76e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PDGFRA—sarcoma	3.75e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.75e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MDM2—sarcoma	3.73e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—HRAS—sarcoma	3.71e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—sarcoma	3.7e-06	2.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—sarcoma	3.66e-06	2.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FOXO1—sarcoma	3.66e-06	2.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PDGFRB—sarcoma	3.65e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—sarcoma	3.65e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HRAS—sarcoma	3.62e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—KRAS—sarcoma	3.61e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PDGFRA—sarcoma	3.59e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—sarcoma	3.57e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PLCG1—sarcoma	3.57e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KDR—sarcoma	3.56e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MDM2—sarcoma	3.55e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MDM2—sarcoma	3.55e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HRAS—sarcoma	3.51e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—KRAS—sarcoma	3.49e-06	2.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HRAS—sarcoma	3.48e-06	2.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—sarcoma	3.47e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CTNNB1—sarcoma	3.45e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MDM2—sarcoma	3.44e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—sarcoma	3.43e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KDR—sarcoma	3.42e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MDM2—sarcoma	3.39e-06	2.46e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ENO2—sarcoma	3.36e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HBA1—sarcoma	3.34e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HRAS—sarcoma	3.34e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—JUN—sarcoma	3.34e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—sarcoma	3.33e-06	2.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KDR—sarcoma	3.32e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CTNNB1—sarcoma	3.31e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KIT—sarcoma	3.28e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MDM2—sarcoma	3.27e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—JUN—sarcoma	3.24e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CTNNB1—sarcoma	3.22e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HRAS—sarcoma	3.2e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—sarcoma	3.17e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KDR—sarcoma	3.16e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KIT—sarcoma	3.15e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—NRAS—sarcoma	3.15e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CREB1—sarcoma	3.13e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—SRC—sarcoma	3.12e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—sarcoma	3.1e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—JUN—sarcoma	3.08e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HRAS—sarcoma	3.07e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CTNNB1—sarcoma	3.06e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KIT—sarcoma	3.06e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—NRAS—sarcoma	3.06e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CTNNB1—sarcoma	3.06e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—sarcoma	3.03e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KDR—sarcoma	3.02e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CREB1—sarcoma	3e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—NRAS—sarcoma	3e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—SRC—sarcoma	3e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HRAS—sarcoma	2.97e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CTNNB1—sarcoma	2.97e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—JUN—sarcoma	2.95e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CTNNB1—sarcoma	2.93e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CREB1—sarcoma	2.91e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KIT—sarcoma	2.91e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—NRAS—sarcoma	2.91e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—SRC—sarcoma	2.91e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—NRAS—sarcoma	2.88e-06	2.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—sarcoma	2.87e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PLCG1—sarcoma	2.85e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CTNNB1—sarcoma	2.82e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—NRAS—sarcoma	2.8e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—sarcoma	2.79e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KIT—sarcoma	2.79e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CREB1—sarcoma	2.77e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SRC—sarcoma	2.77e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—SRC—sarcoma	2.77e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—sarcoma	2.73e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—KRAS—sarcoma	2.72e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SRC—sarcoma	2.68e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—MYC—sarcoma	2.67e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NRAS—sarcoma	2.66e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NRAS—sarcoma	2.66e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—sarcoma	2.65e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CREB1—sarcoma	2.65e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—SRC—sarcoma	2.65e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—KRAS—sarcoma	2.63e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—sarcoma	2.63e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—MYC—sarcoma	2.59e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MDM2—sarcoma	2.59e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—KRAS—sarcoma	2.58e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NRAS—sarcoma	2.58e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SRC—sarcoma	2.55e-06	1.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—sarcoma	2.55e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NRAS—sarcoma	2.55e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—KRAS—sarcoma	2.51e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MDM2—sarcoma	2.48e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—KRAS—sarcoma	2.48e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MYC—sarcoma	2.48e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NRAS—sarcoma	2.46e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—sarcoma	2.42e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—sarcoma	2.42e-06	1.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MDM2—sarcoma	2.41e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KRAS—sarcoma	2.41e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MYC—sarcoma	2.4e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—sarcoma	2.35e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—sarcoma	2.32e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—sarcoma	2.31e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HRAS—sarcoma	2.31e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MDM2—sarcoma	2.29e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KRAS—sarcoma	2.29e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KRAS—sarcoma	2.29e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MYC—sarcoma	2.29e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCND1—sarcoma	2.25e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HRAS—sarcoma	2.24e-06	1.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—sarcoma	2.24e-06	1.62e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CTNNB1—sarcoma	2.23e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KRAS—sarcoma	2.22e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—sarcoma	2.22e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HRAS—sarcoma	2.19e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MDM2—sarcoma	2.19e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KRAS—sarcoma	2.19e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCND1—sarcoma	2.16e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—JUN—sarcoma	2.16e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—sarcoma	2.15e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CTNNB1—sarcoma	2.14e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HRAS—sarcoma	2.13e-06	1.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KRAS—sarcoma	2.11e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HRAS—sarcoma	2.11e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCND1—sarcoma	2.1e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—JUN—sarcoma	2.09e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CTNNB1—sarcoma	2.08e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ENO2—sarcoma	2.07e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HBA1—sarcoma	2.06e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—sarcoma	2.05e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HRAS—sarcoma	2.05e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SRC—sarcoma	2.02e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCND1—sarcoma	2e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—JUN—sarcoma	1.99e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CTNNB1—sarcoma	1.98e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—sarcoma	1.96e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—sarcoma	1.96e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HRAS—sarcoma	1.95e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HRAS—sarcoma	1.95e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRAS—sarcoma	1.94e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SRC—sarcoma	1.94e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCND1—sarcoma	1.91e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—JUN—sarcoma	1.91e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CTNNB1—sarcoma	1.89e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HRAS—sarcoma	1.89e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—sarcoma	1.89e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SRC—sarcoma	1.88e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRAS—sarcoma	1.86e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HRAS—sarcoma	1.86e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—sarcoma	1.83e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRAS—sarcoma	1.81e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MYC—sarcoma	1.81e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HRAS—sarcoma	1.8e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SRC—sarcoma	1.79e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—sarcoma	1.77e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PLCG1—sarcoma	1.76e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—sarcoma	1.74e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MYC—sarcoma	1.74e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRAS—sarcoma	1.72e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SRC—sarcoma	1.71e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—sarcoma	1.7e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MYC—sarcoma	1.68e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KRAS—sarcoma	1.67e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—sarcoma	1.67e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—sarcoma	1.65e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRAS—sarcoma	1.65e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KRAS—sarcoma	1.6e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MYC—sarcoma	1.6e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—sarcoma	1.57e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KRAS—sarcoma	1.56e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MYC—sarcoma	1.53e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—sarcoma	1.5e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—sarcoma	1.48e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KRAS—sarcoma	1.48e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—sarcoma	1.43e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HRAS—sarcoma	1.42e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KRAS—sarcoma	1.42e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—sarcoma	1.38e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HRAS—sarcoma	1.36e-06	9.87e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HRAS—sarcoma	1.32e-06	9.57e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—sarcoma	1.32e-06	9.52e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—sarcoma	1.26e-06	9.11e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HRAS—sarcoma	1.26e-06	9.11e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HRAS—sarcoma	1.2e-06	8.71e-06	CbGpPWpGaD
